For more information visit [ Ссылка ]
Dendritic cells (DCs) are a heterogeneous population of myeloid immune cells that act as peripheral sentinels specializing in antigen uptake, processing, and presentation. They are responsible for initiating adaptive immune responses, particularly antigen-specific activation of naive T cells, but also play a pivotal role as critical modulators of thymic and peripheral immune tolerance. This unique ability of DCs to induce either an inflammatory or tolerogenic response placed them in a central position in research focusing on the development of effective immunotherapies for the treatment of cancer and infectious diseases. This mini webinar gives an introduction to Miltenyi Biotec’s innovative DC research product solutions and application workflows to support your research. It covers highlight topics, including primary DC isolation and Mo-DC generation, as well as the analysis of DC subpopulations.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

свернуть